Anti TNF-α therapy for ulcerative colitis: current status and prospects for the future
Sign Up to like & getrecommendations! Published in 2017 at "Expert Review of Clinical Immunology"
DOI: 10.1080/1744666x.2017.1243468
Abstract: ABSTRACT Introduction: Anti TNF-α agents have become a significant advance in the management of ulcerative colitis, proving to induce, with rapid onset, clinical and endoscopic remission. However, there is still a considerable unmet medical need… read more here.
Keywords: anti tnf; ulcerative colitis; tnf therapy; therapy ulcerative ... See more keywords
Tofacitinib as a Rescue Therapy for Ulcerative Colitis in Pregnancy
Sign Up to like & getrecommendations! Published in 2024 at "Inflammatory Bowel Diseases"
DOI: 10.1093/ibd/izae076
Abstract: Tofacitinib, a potentially teratogenic nonselective Janus Kinase inhibitor was used as salvage therapy for ulcerative colitis during pregnancy with corticosteroids, maintenance ustekinumab, and rectal 5-ASA therapy. Corticosteroid-free remission ensued, resulting in term delivery without congenital… read more here.
Keywords: colitis pregnancy; therapy ulcerative; ulcerative colitis; therapy ... See more keywords
Targeting IL-13 as a Host-Directed Therapy Against Ulcerative Colitis
Sign Up to like & getrecommendations! Published in 2018 at "Frontiers in Cellular and Infection Microbiology"
DOI: 10.3389/fcimb.2018.00395
Abstract: The role of interleukin-13 in mediating ulcerative colitis remains under scrutiny. Compelling evidence from both man and mouse suggests that IL-13 not only contributes to the pathology associated with disease but is also involved in… read more here.
Keywords: directed therapy; therapy ulcerative; host directed; colitis ... See more keywords